相关实验视频
Updated: Jul 10, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
保持你的马:冲动性,深度大脑刺激,和药物治疗帕金森症
Michael J Frank1, Johan Samanta, Ahmed A Moustafa
1Department of Psychology and Program in Neuroscience, University of Arizona, Tucson, AZ 85721, USA. mfrank@u.arizona.edu
概括
帕金森病的深度大脑刺激 (DBS) 改善了运动功能,但通过损害冲突下的决策,增加了冲动性. 多巴胺药物影响学习,而不是这种特定的冲动性.
科学领域:
- 神经科学是一个神经科学.
- 认知科学 认知科学
- 神经学 神经学
背景情况:
- 脑下核的深度大脑刺激 (DBS) 是帕金森病运动症状的关键治疗方法.
- 然而,DBS可以诱导认知副作用,包括冲动性,影响患者的生活质量.
研究的目的:
- 为了研究底核DBS如何影响决策过程,特别是在冲突期间减慢速度的能力.
- 区分DBS和多巴胺作用药物对帕金森病患者冲动性和学习的影响.
主要方法:
- 利用神经计算模型来预测行为变化.
- 评估了帕金森病患者的决策表现,这些患者有或没有亚thalamic核 DBS.
- 检查了多巴胺类药物状态对决策冲突和从结果中学习的影响.
主要成果:
- 脑下核DBS选择性地影响了在高冲突下减缓决策的能力,导致冲动性增加.
- 这种DBS诱导的冲动性是独立于多巴胺药物治疗的.
- 多巴胺类药物降低了从负面决策结果中学习的能力,这表明了不同的机制.
结论:
- 用DBS治疗的帕金森病患者的冲动性源于与决策冲突处理有关的独特机制.
- 多巴胺类药物影响与从负面反中学习相关的单独过程.
- 这些发现凸显了帕金森病中神经调节,药物和认知功能之间的复杂相互作用.
相关概念视频
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

